-+ 0.00%
-+ 0.00%
-+ 0.00%

Guided Therapeutics partners with Türkiye Health Ministry on LuViva cervical cancer screening study

PUBT·09/09/2026 13:01:14
Listen to the news
Guided Therapeutics partners with Türkiye Health Ministry on LuViva cervical cancer screening study
  • Guided Therapeutics reached a collaboration with Türkiye’s Ministry of Health to co-develop LuViva as a primary cervical cancer screening test.
  • Partnership begins with an 800-patient clinical study to refine AI pattern-recognition for real-time detection of early cellular changes.
  • Ministry of Health will fund the six-month study, including purchases of LuViva devices and single-use Cervical Guides.
  • Successful results could position LuViva to screen up to 20 million Turkish women annually with immediate results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guided Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260909993239) on September 09, 2026, and is solely responsible for the information contained therein.